Distribution of transforming growth factor-β isoforms in human immunodeficiency virus-1 encephalitis

Human Pathology

Volumn 27, Issue 7, 1996, Pages 643-649

  Johnson, M D ^a   Gold, L I ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

acquired immunodeficiency virus; cytokines; growth factors; human immunodeficiency virus 1 encephalitis; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MALE; PATHOPHYSIOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TOXOPLASMOSIS; VIRUS ENCEPHALITIS;

EID: 0030004008     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90392-5     Document Type: Article

References (48)

1. Janssen RS, Nwanyanwu OC, Selik RM, et al: Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42:1472-1476, 1992
2. Maj M, Janssen R, Satz P, et al: The World Health Organization's cross-cultural study on neuropsychiatrie aspects of infection with the human immunodeficiency virus 1 (HIV-1). Br J Psychiatry 159:351-356, 1991
3. Reardon J, Singleton J, Wilson MJ, et al: Epidemiology of HIV encephalopathy (HIV-E): Reported frequencies in California, 1988-1991. Eighth International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands, 1992 (abstr)
4. Price RW, Brew B, Sidtis J, et al: The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592, 1988
5. Bacellar H, Munoz A, Miller EN, et al: Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 44:1892-1900, 1994
6. DeGirolami U, Smith TW, Henin D, et al: Neuropathology of the acquired immunodeficiency syndrome. Arch Pathol Lab Med 114:643-655, 1990
7. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathology 1:163-175, 1991
8. Weller M, Stevens A, Sommer N, et al: Comparative analysis of cytokine patterns in immunological, infectious and oncological neurological disorders. J Neurol Sci 104:215-221, 1991
9. Wesselingh SL, Power C, Glass JD, et al: Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33:576-582, 1993
10. Achim CL, Schrier RD, Wiley CA: Immunopathogenesis of HIV encephalitis. Brain Pathology 1:177-184, 1991
11. Dickson DW, Lee SC, Mattiace LA, et al: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83, 1993
12. Owens T, Renno T, Taupin V, et al: Inflammatory cytokines in the brain: Does the CNS shape immune responses. Immunol Today 15:566-571, 1994
13. Moses H: The biological actions of transforming growth factor β, in Sara V (ed): Growth factors: From genes to clinical application. New York, NY, Raven, 1990, pp 141-155
14. Cheifetz S, Weatherbee J, Tsang M, et al: The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409-415, 1987
15. Ohta M, Greenberger JS, Anklesaria P, et al: Two forms of transforming growth factor-β distinguished by multipotential haematopoetic progenitor cells. Nature 329:539-541, 1987
16. Wahl SM, Hunt DA, Wakefield L, et al: Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84:5788-5792, 1987
17. Adams DH, Hathaway M, Shaw J, et al: Transforming growth factor-β induces human T lymphocyte migration in vitro. J Immunol 147:609-612, 1991
18. Parekh T, Saxena B, Reibman J, et al: Neutrophil chemotaxis in response to transforming growth factor-β isoforms (TGF/31, TGFβ2, and TGFβ3) is mediated by fibronectin. J Immunol 152:2456-2466, 1994
19. Fava R, Olsen N, Keski-Oja J, et al: Active and latent forms of transforming growth factor β activity in synovial effusions. J Exp Med 169:292, 1989
20. Lafyatis R, Thompson NL, Remmers EF, et al: Transforming growth factor-β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. J Immunol 143:1142-1148, 1989
21. Lee HM, Rich S: Co-stimulation of T cell proliferation by transforming growth factor β1. J Immunol 147:1127-1133, 1991
22. Swain S, Huston G, Tonkonogy S, et al: Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lympokine secretion pattern and cell surface phenotype. J Immunol 147:2991-3000, 1991
23. Salgame P, Abrams JS, Clayberger C, et al: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282, 1991
24. Kehrl JH, Taylor AS, Delsing GA, et al: Further studies on the role of transforming growth factor-β in human B cell function. J Immunol 143:1868-1874, 1989
25. Kehrl JH, Thevenin C, Rieckmann P, et al: Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 143:1868-1874, 1989
26. Rook AH, Kehrl JH, Wakefield LM, et al: Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916-3920, 1986
27. Ranges GE, Figari IS, Espevik T, et al: Inhibition of cytotoxic T cell development by transforming growth factor B and reversal by recombinant tumor necrosis factor a. J Exp Med 166:991-998, 1987
28. Tsunarvaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262, 1988
29. McCartney-Francis N, Mizel D, Wong H, et al: TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 4:27-35, 1990
30. Grotendorst GR, Smale G, Peniev D: Production of transforming growth factor β by human peripheral blood monocytes and neutrophils. J Cell Physiol 140:396-402, 1989
31. Wiseman DM, Polverini PJ, Kamp DW, et al: Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157:793-800, 1988
32. Chantry D, Turner M, Abney E, et al: Modulation of cytokine production by transforming growth factor-β. J Immunol 142:4295-4300, 1989
33. Turner M, Chantry D, Feldmann M, et al: Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2:211-216, 1990
34. Pelton RW, Saxena B, Jones M, et al: Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: Expression of patterns suggest multiple roles during embryonic development. J Cell Biol 115:109-115, 1991
35. Johnson MD, Gold LI, Moses HL: Evidence for transforming growth factor-β expression in human leptomeningeal cells and transforming growth factor-β-like activity in human cerebrospinal fluid. Lab Invest 67:360-368, 1992
36. Hauser IA, Setter E, Bell L, et al: Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am J Pathol 143:173-180, 1993
37. Basson CT, Kocher O, Basson MD, et al: Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGFβ1 correlates with reciprocal effects on cell migration. J Cell Physiol 153:118-128, 1992
38. Johnson MD, Gold LI: Evidence for TGFβ expression and its regulation of fibronectin in the leptomeninges in HIV-1 encephalitis. Brain Pathology 4:484, 1994 (abstr P22-11)
39. Lindlholm D, Castren E, Kiefer R, et al: Transforming growth factor-β1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395-400, 1992
40. Suzumura A, Sawado M, Yamamato H, et al: Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J Immunol 151:2150-2158, 1993
41. Morganti-Kossmann MC, Kossmann T, Brandes ME, et al: Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J Neuroimmunol 39:163-173, 1992
42. Benveniste EN, Kwon J, Chung WJ, et al: Differential modulation of astrocyte cytokine gene expression by TGFβ. J Immunol 153:5210-5221, 1994
43. Wahl SM, Allen JB, McCartney-Francis N, et al: Macrophage and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 173:981-991, 1991
44. Kekow J, Wachsman W, McCutchan JA, et al: Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci U S A 87:8321-8325, 1990
45. Wahl SM, Allen JB, McCartney-Francis N, et al: Transforming growth factor beta: A potential macrophage and astrocyte-derived mediator of CNS dysfunction in AIDS. J Exp Med 173:891-899, 1991
46. Zauli G, Davis BR, Re MC, et al: tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036-3043, 1992
47. Segarini PR: TGF-β receptors: A complicated system of multiple binding proteins. Biochim Biophys Acta 1155:269-275, 1993
48. Cheifetz S, Hernandez H, Laiho M, et al: Distinct transforming growth factor-β receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 265:20533-20538, 1990